Alivus Life Sciences to host investor meetings on Sep 9 in Mumbai
- Alivus Life Sciences to hold one-on-one meetings with four investors on September 9, 2026
- Participants include Breakout Capital, UTI, Kotak Mutual Fund, and Param Capital
- All sessions are scheduled as in-person meetings in Mumbai
- Disclosure made under Regulation 30 of SEBI LODR Regulations, 2015
*this image is generated using AI for illustrative purposes only.
Alivus Life Sciences Limited will host one-on-one meetings with four institutional investors and analysts in Mumbai on September 9, 2026.
The company disclosed the schedule under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The meetings are scheduled as in-person sessions.
Meeting Schedule
Alivus Life Sciences confirmed engagements with Breakout Capital, UTI, Kotak Mutual Fund, and Param Capital. All sessions are set for the same date.
| Date | Investor | Mode | Location | Type |
|---|---|---|---|---|
| September 9, 2026 | Breakout Capital | In-person | Mumbai | One on One |
| September 9, 2026 | UTI | In-person | Mumbai | One on One |
| September 9, 2026 | Kotak Mutual Fund | In-person | Mumbai | One on One |
| September 9, 2026 | Param Capital | In-person | Mumbai | One on One |
The company noted that the schedule or mode of meeting may change due to exigencies on the part of the investor, analyst, or the company. Rudalf Correa, Company Secretary and Compliance Officer, signed the disclosure.
Historical Stock Returns for Alivus Life Sciences
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.22% | -2.40% | +3.17% | +49.94% | +48.65% | +104.90% |
What specific strategic updates or financial guidance is Alivus Life Sciences likely to present to these key institutional investors during the September 9 meetings?
How might the engagement with major funds like UTI and Kotak Mutual Fund influence short-term trading volume and price volatility for Alivus shares following the disclosure?
Are there indications that Alivus is preparing for a significant corporate action, such as a new product launch, partnership, or fundraising, that necessitates this concentrated investor outreach?
15
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
